Biomedical Engineering Reference
In-Depth Information
72. Lew DH, Yoon JH, Hong JW, Tark KC (2010) Efficacy of antiadhesion barrier solution on
periimplant capsule formation in a white rat model. Ann Plast Surg 65(2):254-258
73. Li J, Zhang YP, Kirsner RS (2003) Angiogenesis in wound repair: angiogenic growth factors
and the extracellular matrix. Microsc Res Tech 60(1):107-114
74. Madlener M, Parks WC, Werner S (1998) Matrix metalloproteinases (MMPs) and their phys-
iological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair.
Exp Cell Res 242(1):201-210
75. Maller O, Martinson H, Schedin P (2010) Extracellular matrix composition reveals complex
and dynamic stromal-epithelial interactions in the mammary gland. J Mammary Gland Biol
Neoplasia 15(3):301-318
76. Manuel JA, Gawronska-Kozak B (2006) Matrix metalloproteinase 9 (MMP-9) is upregulated
during scarless wound healing in athymic nude mice. Matrix Biol 25(8):505-514
77. Matrisian LM, Wright J, Newell K, Witty JP (1994) Matrix-degrading metalloproteinases in
tumor progression. Princess Takamatsu Symp 24:152-161
78. Metzmacher I, Ruth P, Abel M, Friess W (2007) In vitro binding of matrix metalloprotei-
nase-2 (MMP-2) MMP-9 and bacterial collagenase on collagenous wound dressings. Wound
Repair Regen 15(4):549-555
79. Morrison CJ, Overall CM (2006) TIMP independence of matrix metalloproteinase (MMP)-2
activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-
MMP catalytic and hemopexin C domains. J Biol Chem 281(36):26528-26539
80. Muller M, Trocme C, Lardy B, Morel F, Halimi S, Benhamou PY (2008) Matrix metallopro-
teinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound
healing. Diabet Med 25(4):419-426
81. Murshed M, McKee MD (2010) Molecular determinants of extracellular matrix mineraliza-
tion in bone and blood vessels. Curr Opin Nephrol Hypertens 19(4):359-365
82. Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274(31):21491-21494
83. Nakamura Y, Sato K, Wakimoto N, Kimura F, Okuyama A, Motoyoshi K (2001) A new
matrix metalloproteinase inhibitor SI-27 induces apoptosis in several human myeloid leu-
kemia cell lines and enhances sensitivity to TNF alpha-induced apoptosis. Leukemia 15(8):
1217-1224
84. Neamtu M, Filioreanu AM, Petreus T, Badescu L, Ionescu CR, Cotrutz CE (2010) Involvement
of MMP-8 in tissue response to colagenated fibrillar net in rats. Ann Roman Soc Cell Biol
15(1):236-241
85. Nilsen-Hamilton M, Werb Z, Keshet E (2003) Tissue remodeling. New York Academy of
Sciences, New York, NY
86. Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y (1996) Enhanced production of matrix
metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human
gastric carcinomas. Int J Cancer 69(1):9-16
87. Overall CM, Kleifeld O (2006) Tumour microenvironment—opinion: validating matrix
metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer
6(3):227-239
88. Parks WC, Mecham RP (1998) Matrix metalloproteinases. Academic, San Diego
89. Peled ZM, Phelps ED, Updike DL, Chang J, Krummel TM, Howard EW et al (2002) Matrix
metalloproteinases and the ontogeny of scarless repair: the other side of the wound healing
balance. Plast Reconstr Surg 110(3):801-811
90. Pepper MS (2001) Role of the matrix metalloproteinase and plasminogen activator-plasmin
systems in angiogenesis. Arterioscler Thromb Vasc Biol 21(7):1104-1117
91. Petreus T, Cotrutz CE, Neamtu M, Buruiana EC, Sirbu PD, Neamtu A (2010) Molecular
docking on recomposed versus crystallographic structures of Zn-dependent enzymes and
their natural inhibitors. Proc World Acad Sci Eng Technol 68:1992-1995
92. Petreus T, Cotrutz CE, Neamtu M, Buruiana EC, Sirbu PD, Neamtu A (2010) Understanding
the dynamics-activity relationship in metalloproteases: ideas for new inhibition strategies.
In: AT-EQUAL 2010: 2010 ECSIS Symposium on advanced technologies for enhanced quality
of life: LAB-RS and ARTIPED 2010, pp 83-86
Search WWH ::
Custom Search